Factors associated with emotional distress in newly-diagnosed prostate cancer identified
the ONA take:
According to a new study published in the journal Psycho-Oncology, researchers from the University at Buffalo Department of Community Health and Health Behavior in Buffalo, New York, have identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
For the study, researchers sought to identify factors associated with significant emotional distress in men with newly diagnosed prostate cancer so that may identify acceptable intervention strategies to manage that distress.
Researchers identified 1,425 men with newly diagnosed clinically localized prostate cancer who had not received treatment for their disease yet.
Participants used the Distress Thermometer to report how much distress they were experiencing and identify what problems they experienced in the past week. Results showed that low self-efficacy for decision-making, low confidence in cancer control, masculine identity threat, low optimism, and low resilience were associated with higher emotional distress.
The findings suggest that improving communication about prostate cancer prognosis, providing decision-making support, and referring to brief cognitive behavioral interventions may be useful approaches at mitigating significant emotional distress for those with newly diagnosed prostate cancer.
Researchers identified certain factors associated with emotional distress in men with newly diagnosed prostate cancer.
Sign Up for Free e-newsletters
- Incidence of Post-traumatic Stress Disorder High Among Patients With Cancer
- Long-Term Night Shift Work Associated With Cancer Risk in Women
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- FDA Grants Breakthrough Therapy Designation to Lenvatinib Plus Pembrolizumab for RCC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Breast Cancer Deaths Decrease Sharply Since 2000
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|